These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25865930)

  • 21. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The central versus peripheral antinociceptive effects of μ-opioid receptor agonists in the new model of rat visceral pain.
    Al-Khrasani M; Lackó E; Riba P; Király K; Sobor M; Timár J; Mousa S; Schäfer M; Fürst S
    Brain Res Bull; 2012 Feb; 87(2-3):238-43. PubMed ID: 22079588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS).
    Kalra A; Urban MO; Sluka KA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):257-63. PubMed ID: 11408550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
    Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implication of dopaminergic projection from the ventral tegmental area to the anterior cingulate cortex in μ-opioid-induced place preference.
    Narita M; Matsushima Y; Niikura K; Narita M; Takagi S; Nakahara K; Kurahashi K; Abe M; Saeki M; Asato M; Imai S; Ikeda K; Kuzumaki N; Suzuki T
    Addict Biol; 2010 Oct; 15(4):434-47. PubMed ID: 20731628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sweetened-fat intake sensitizes gamma-aminobutyric acid-mediated feeding responses elicited from the nucleus accumbens shell.
    Newman S; Pascal L; Sadeghian K; Baldo BA
    Biol Psychiatry; 2013 May; 73(9):843-50. PubMed ID: 23312563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maturational alterations in constitutive activity of medial prefrontal cortex kappa-opioid receptors in Wistar rats.
    Sirohi S; Walker BM
    J Neurochem; 2015 Nov; 135(4):659-65. PubMed ID: 26257334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of mu-opioid receptor selectively potentiates NMDA-induced outward currents in rat locus coeruleus neurons.
    Koyama S; Akaike N
    Neurosci Res; 2008 Jan; 60(1):22-8. PubMed ID: 17976846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of mu-opioid receptors inhibits lordosis behavior in estrogen and progesterone-primed female rats.
    Acosta-Martinez M; Etgen AM
    Horm Behav; 2002 Feb; 41(1):88-100. PubMed ID: 11863387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
    Sterious SN; Walker EA
    J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
    Alt A; McFadyen IJ; Fan CD; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropeptide FF exerts pro- and anti-opioid actions in the parabrachial nucleus to modulate food intake.
    Nicklous DM; Simansky KJ
    Am J Physiol Regul Integr Comp Physiol; 2003 Nov; 285(5):R1046-54. PubMed ID: 14557236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A naloxonazine sensitive (mu1 receptor) mechanism in the parabrachial nucleus modulates eating.
    Chaijale NN; Aloyo VJ; Simansky KJ
    Brain Res; 2008 Nov; 1240():111-8. PubMed ID: 18805404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of mu opioid receptors in the medial preoptic area following copulation in male rats.
    Coolen LM; Fitzgerald ME; Yu L; Lehman MN
    Neuroscience; 2004; 124(1):11-21. PubMed ID: 14960335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of co-administration of 2-arachidonylglycerol (2-AG) and a selective µ-opioid receptor agonist into the nucleus accumbens on high-fat feeding behaviors in the rat.
    Parker KE; McCall JG; McGuirk SR; Trivedi S; Miller DK; Will MJ
    Brain Res; 2015 Aug; 1618():309-15. PubMed ID: 26100333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neural activation patterns underlying basolateral amygdala influence on intra-accumbens opioid-driven consummatory versus appetitive high-fat feeding behaviors in the rat.
    Parker KE; McCabe MP; Johns HW; Lund DK; Odu F; Sharma R; Thakkar MM; Cornelison DD; Will MJ
    Behav Neurosci; 2015 Dec; 129(6):812-21. PubMed ID: 26501175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Stomach-Derived Hormone Ghrelin Increases Impulsive Behavior.
    Anderberg RH; Hansson C; Fenander M; Richard JE; Dickson SL; Nissbrandt H; Bergquist F; Skibicka KP
    Neuropsychopharmacology; 2016 Apr; 41(5):1199-209. PubMed ID: 26424164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid-induced regulation of gene expression in PC12 cells stably transfected with mu-opioid receptor.
    Zarnegar P; Persson AI; Ming Y; Terenius L
    Neurosci Lett; 2006 Apr; 396(3):197-201. PubMed ID: 16377088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.